Connect with us

Technology

Integra Connect Teams Up with Jaan Health and Sweeten Health to Advance Chronic Care Management for Oncology

Published

on

The collaboration will enable transformational, proactive care at scale across the largest oncology provider footprint in the United States

WEST PALM BEACH, Fla., Oct. 15, 2024 /PRNewswire/ — Integra Connect, a leader in value-based, precision medicine solutions for specialty care, today announced a strategic collaboration with the leading chronic care management and proactive care company Jaan Health and innovative care management provider Sweeten Health. More than 4,000 oncologists providing cancer care across 100+ physician group practices, NCI-designated cancer centers, academic medical centers and health systems rely on solutions from Integra Connect to drive performance in value-based care (VBC) models.  Jaan Health’s flagship care management platform Phamily and Sweeten Health nurses will enable this network to build and scale profitable Chronic Care Management (CCM) service lines with 10x labor efficiency while driving performance under alternative payment models.

Integra Connect Teams Up with Jaan Health and Sweeten Health to Advance Chronic Care Management for Oncology

Phamily is used by 150+ healthcare organizations who run care management programs with their own staff or via a turnkey solution in which highly trained Sweeten Health nurses are integrated into practice workflows.  Phamily’s AI-driven technology enables consistent patient check-ins, follow-ups, and support, allowing medical teams to focus on delivering exceptional care while ensuring fair compensation for between-visit services. Healthcare organizations utilizing the Phamily platform have seen remarkable results, including:

$400,000 in revenue per 1000 patients with 40% profit margins5-10x increase in caseloads per care manager90 days to launch a service line at scale and generate revenue9.5/10 patient satisfaction ratings95% patient engagement monthly

Chronic Care Management has historically been underutilized because providers have found it too difficult and time-consuming. But in 2024, over 60% of Phamily customers are on track to achieve top-decile programs that deliver this critical patient care at scale.

Jeffrey A. Scott, MD, Chief Medical Officer at Integra Connect, emphasized the transformative potential of this partnership: “By integrating Jaan Health’s innovative platform Phamily into our existing solutions, we can drive care transformation at an unprecedented scale. And from the start, we were impressed by the results Sweeten Health has delivered for oncology practices in our network. This collaboration will enable our network of practices to provide more consistent, proactive care between visits, helping avoid unnecessary ED visits and inpatient stays for cancer patients and support more sustainable practice operations.”

“Cancer patients are trapped in the overlap of extreme medical and financial burden. They need continuous between visit care and support that our health systems all too often either ration or simply cannot afford,” said Nabeel Kaukab, CEO of Jaan Health. “Our partnership with Integra Connect is a significant step forward in ensuring these most vulnerable patients receive the comprehensive care they desire and deserve. Integra Connect’s extensive experience in oncology care transformation makes them an ideal partner to expand the reach and the impact of our solutions while simultaneously driving improved financial performance for cancer care.”

Nisha Bhalla, CEO of Sweeten Health, which provides nursing services using the Phamily platform, added: “As a partner utilizing Phamily to deliver high-quality care for smaller practices and those without internal capacity, we’ve seen firsthand how this technology empowers nurses to provide exceptional chronic care management. This partnership between Integra Connect and Jaan Health will expand access to crucial between-visit care for even more oncology patients.”

Leaders from Integra Connect, Jaan Health, and Sweeten Health will all speak at the 14th Annual Summit of the Association for Value Based Cancer Care in New York this week.

About Integra Connect, LLC.
Integra Connect is a value-based, precision medicine company that leads the industry in real-world data and analytics capabilities for oncology. With decades of value-based care expertise and sophisticated technologies, it enables specialty care providers, health systems, payers, and life sciences companies to improve patient outcomes, provider decision-making, business operations and performance, and clinical research for success under value-based care models.

To learn more, please visit: www.integraconnect.com

About Jaan Health

Founded in 2013, Jaan Health is a leading chronic care management and proactive care company serving healthcare providers. For nearly a decade, the company has leveraged easy-to-use, AI-driven technology to enable medical groups, health systems, and ACOs to better deliver high-quality, high-ROI proactive care across their entire population. Its core software platform, Phamily, has transformed chronic disease management with simple technology that enables physicians and care teams to focus on increasing patient care via consistent check-ins, follow-ups, and support at population scale. The platform helps ensure healthcare providers are compensated fairly for providing high-quality care between office visits.

For more information, please visit: www.phamily.com

About Sweeten Health

Sweeten Health provides a turnkey solution for chronic care management (CCM), enabling healthcare practices to improve patient outcomes while generating additional revenue. They offer remote clinical support and virtual check-ins with licenses nurse that allows patients to stay engaged with their care plans. Their platform supports practices by improving patient engagement, tracking compliance, and providing immediate interventions when needed. This helps healthcare providers increase their revenue by up to 30%, with no upfront costs or minimum requirements.

For more information, please visit: www.sweetenhealth.com

Media Contact

Alyssa Drew

Jaan Health

alyssa.drew@jaanhealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/integra-connect-teams-up-with-jaan-health-and-sweeten-health-to-advance-chronic-care-management-for-oncology-302275704.html

SOURCE Integra Connect

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

America’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search

Published

on

By

The Regeneron Science Talent Search Celebrates and Rewards Today’s Most Talented Young Minds Driving Innovation and Progress through Scientific Exploration

TARRYTOWN, N.Y. and WASHINGTON, Jan. 23, 2025 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) today announced the top 40 finalists in the 2025 Regeneron Science Talent Search (STS), the U.S.’s longest-running and most distinguished science, technology, engineering and math (STEM) competition for high school seniors.

Now in its 84th year, the competition identifies extraordinary young minds who blend scientific talent, curiosity and bold leadership to drive meaningful change for society. Regeneron Science Talent Search alumni have gone on to win 13 Nobel Prizes, 23 MacArthur Fellowships, and have founded numerous world-changing companies, including Regeneron.

This year’s finalists’ research projects span a wide range of critical topics, reflecting their diverse expertise and commitment to tackling society’s most pressing issues. Research areas include species migration, early detection crop protection, and low-cost pest treatment and management. Other finalists focused on disease diagnosis using tools like AI, and progression analysis, as well as genetic and cancer therapies.

“Congratulations to this year’s remarkable finalists. Participating in the Regeneron – then Westinghouse – Science Talent Search was a moment of revelation for me — it opened my eyes to the possibility of using science to improve lives,” said George D. Yancopoulos, M.D., Ph.D., Co-Founder, Co-Chairman, President and Chief Scientific Officer of Regeneron, who was a top winner in 1976. “Regeneron now helps millions of people around the world facing serious diseases, which is a testament to what is possible when young scientific talent is nurtured. I see that same potential to transform our world in these finalists, and I look forward to their future contributions to science and to human health.”

The finalists were selected from 300 top scholars and nearly 2,500 total entrants, reflecting the exceptional magnitude and caliber of this year’s competition, and underscoring the importance of nurturing STEM education, along with supporting accessibility for programs that promote scientific literacy and career readiness.

“We celebrate this exceptional group of Regeneron Science Talent Search finalists for their outstanding achievements,” said Maya Ajmera, President and CEO of Society for Science and Executive Publisher of Science News. “These young people represent the future of innovation. By nurturing the next generation of scientific and engineering leaders, we are investing in a stronger economy and a better tomorrow, fueled by scientific and technological breakthroughs.”

Finalists will participate in a week-long competition from March 6-12, 2025, where they will undergo a rigorous judging process and compete for more than $1.8 million in awards. They will also have an opportunity to interact with leading scientists and share research with the public on March 9, both in person and virtually. The top 10 Regeneron Science Talent Search 2025 winners will be announced during an awards ceremony on March 11, streamed live from Washington D.C.

More than $3 million in awards will be distributed throughout the Regeneron Science Talent Search in total. Each finalist will be awarded at least $25,000, with the top 10 awards ranging from $40,000 to $250,000. The top 300 scholars, each of whom receive $2,000 and each of whose schools will receive $2,000 to support math and science programs, a critical investment toward their future as scientific leaders, and our society’s future fueled by innovation and progress. The awards, designated for educational purposes, are an investment in students who demonstrate exceptional promise, emphasizing integrity and merit while also supporting schools and communities to inspire future scientific leadership and innovation.

Regeneron Science Talent Search 2025 Fast Facts

The Regeneron Science Talent Search 2025 finalists represent 39 schools across 16 U.S. states. They are competing for more than $1.8 million, with a top prize of $250,000.Forty finalists were selected from 300 top scholars and nearly 2,500 total entrants, based on the originality and creativity of their scientific research, as well as their achievement and leadership both inside and outside of the classroom.Finalist projects cover a wide range of science disciplines, including animal sciences, behavioral science, biochemistry, bioengineering, cellular and molecular biology, chemistry, computational biology and bioinformatics, earth and planetary science, engineering, environmental science, medicine and health genomics, materials science, mathematics, neuroscience, computer science, animal sciences, physics, plant sciences, social science and space science.

For a list of this year’s finalists, visit https://www.societyforscience.org/regeneron-sts/2025-finalists/  

About the Regeneron Science Talent Search
The Regeneron Science Talent Search, a program of Society for Science since 1942, is the U.S.’s oldest and most prestigious science and math competition for high school seniors. Each year, approximately 2,500 student entrants submit original research in critically important scientific fields of study and are judged by leading experts in their fields. Unique among high school competitions in the U.S. and around the world, the Regeneron Science Talent Search focuses on identifying, inspiring and engaging the nation’s most promising young scientists who are creating the ideas that could solve society’s most urgent challenges.

In 2017, Regeneron became only the third sponsor of the Science Talent Search to help reward and celebrate the best and brightest young minds and encourage them to pursue careers in STEM as a way to positively impact the world. Through its 10-year, $100 million commitment, Regeneron nearly doubled the overall award distribution to $3.1 million annually, increasing the top award to $250,000 and doubling the awards for the top 300 scholars to $2,000 and their schools to $2,000 for each enrolled scholar to inspire more young people to engage in science.

Learn more at https://www.societyforscience.org/regeneron-sts/.

About Society for Science
Society for Science is a champion for science, dedicated to promoting the understanding and appreciation of science and the vital role it plays in human advancement. Established in 1921, Society for Science is best known for its award-winning journalism through Science News and Science News Explores, its world-class science research competitions for students, including the Regeneron Science Talent Search, the Regeneron International Science and Engineering Fair and the Thermo Fisher Scientific Junior Innovators Challenge, and its outreach and equity programming that seeks to ensure that all students have an opportunity to pursue a career in STEM. A 501(c)(3) membership organization, Society for Science is committed to inform, educate and inspire. Learn more at www.societyforscience.org and follow us on Facebook, Twitter, Instagram and Snapchat (Society4Science).

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.

Regeneron believes that operating as a good corporate citizen is crucial to delivering on our mission. We approach corporate responsibility with three goals in mind: to improve the lives of people with serious diseases, to foster a culture of integrity and excellence and to build sustainable communities. Regeneron is proud to be included on the Dow Jones Sustainability World Index and the Civic 50 list of the most “community-minded” companies in the U.S. Throughout the year, Regeneron empowers and supports employees to give back through our volunteering, pro bono and matching gift programs. Our most significant philanthropic commitments are in the area of early science education, including the Regeneron Science Talent Search and the Regeneron International Science and Engineering Fair (ISEF).

For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.

Media Contacts
Joseph Brown, Regeneron
386-283-1323, joseph.brown2@regeneron.com  

Gayle Kansagor, Society for Science
703-489-1131, gkansagor@societyforscience.org 

View original content to download multimedia:https://www.prnewswire.com/news-releases/americas-top-40-high-school-scientists-to-compete-for-1-8-million-in-awards-at-prestigious-regeneron-science-talent-search-302358841.html

SOURCE Society for Science

Continue Reading

Technology

Cloud Foundry Day Announced for May 14 in Palo Alto, Open Call for Proposals

Published

on

By

Technical conference for popular developer open source technologies

SAN FRANCISCO, Jan. 23, 2025 /PRNewswire/ — Cloud Foundry Foundation today announced Cloud Foundry Day will be held on Wednesday, May 14  in Palo Alto, California, and has opened the call for session proposals.

The one-day event is a technical conference for the Cloud Foundry community – including developers, contributors, maintainers, and end-users of the open source project – to explore the latest innovations and discuss best practices for delivering superior developer experiences at companies of all sizes.

Cloud Foundry has long been the industry-standard open source cloud application platform, and with advancements such as Korifi and Paketo Buildpacks, it continues to deliver a best-in-class developer experience on Kubernetes. Cloud Foundry Day serves as a forum for collaboration, fostering connections within the technical community and with end-users and member companies alike.

“Bringing the Cloud Foundry community together at this event is a testament to the value of face-to-face interactions in driving open source innovation,” said Chris Clark, program manager for Cloud Foundry at the Linux Foundation. “Our global community’s reach is vast, and this event provides a key platform for knowledge sharing and collaboration.”

In addition to the Palo Alto event, Cloud Foundry announced a European Cloud Foundry Day will be held in Frankfurt, Germany on October 7, 2025.

The event’s programming will be curated by the community-sourced program committee and will include keynotes, technical sessions, and networking opportunities. The call for proposals (CFP) is now open and invites submissions for technical sessions, panels, and case studies. Submissions are encouraged from individuals and organizations with expertise in Cloud Foundry, Kubernetes, Paketo Buildpacks, Korifi, and related technologies. The CFP submission deadline is February 23, 2025. Accepted speakers will be notified by March 4, 2025. For more information on submission guidelines and topics, visit the event’s CFP page.

For those interested in supporting Cloud Foundry Day, the Sponsorship Prospectus is now available. The registration fee for the event is $50. Attendees can register and find additional details on the event’s official website.

Cloud Foundry is an open source technology backed by the largest technology companies in the world, including, SAP, VMware by Broadcom, Comcast, and Bloomberg, and is being used by leaders in manufacturing, telecommunications and financial services. Only Cloud Foundry delivers the velocity needed to continuously deliver apps at the speed of business. Cloud Foundry’s container-based architecture helps deploy apps written in any language on a choice of cloud platforms — Amazon Web Services (AWS), Google Cloud Platform (GCP), Microsoft Azure, OpenStack, and more. With a robust services ecosystem and simple integration with existing technologies, Cloud Foundry is the modern standard for deploying mission critical apps at global organizations.

About Cloud Foundry Foundation
Cloud Foundry is a collection of open source technologies being used by leaders in manufacturing, telecommunications and financial services. Only Cloud Foundry delivers the velocity needed to continuously deliver apps at the speed of business. Cloud Foundry’s container-based architecture helps deploy apps written in any language on a choice of cloud platforms — Amazon Web Services (AWS), Google Cloud Platform (GCP), Microsoft Azure, OpenStack, and more. With a robust services ecosystem and simple integration with existing technologies, Cloud Foundry is the modern standard for deploying mission critical apps at global organizations.

The Foundation projects include Cloud Foundry, Paketo Buildpacks, Korifi, BOSH, Open Service Broker API, CredHub, and more. Cloud Foundry is hosted by The Linux Foundation and is an Apache 2.0 licensed project available on GitHub. To learn more, visit www.cloudfoundry.org.

The Linux Foundation has registered trademarks and uses trademarks. For a list of trademarks of The Linux Foundation, please see our trademark usage page. Linux is a registered trademark of Linus Torvalds.

Contact:
Joe Eckert
Eckert Communications
jeckert@eckertcomms.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cloud-foundry-day-announced-for-may-14-in-palo-alto-open-call-for-proposals-302358890.html

SOURCE Cloud Foundry Foundation

Continue Reading

Technology

Simple Proof Raises Pre-Seed Round to Protect Digital Truth Using Bitcoin Technology

Published

on

By

NEW YORK, Jan. 23, 2025 /PRNewswire/ — Simple Proof, a pioneer in Bitcoin-based data integrity solutions, announced today its pre-seed funding round led by ego death capital and Wolf. The investment will accelerate the development of Simple Proof’s Immutable Proof service, which leverages Bitcoin‘s Timechain and the OpenTimestamps protocol to create permanent, tamper-proof records of digital files.

In an era where AI-generated content threatens information authenticity, Simple Proof’s platform enables organizations to definitively prove when digital records were created and verify they haven’t been altered. Most notably, their experience demonstrates that even nation-state level deployments for national public records can be done as quickly as a few days thanks to their easy integrations. The technology creates an immutable timestamp of files by recording their unique digital fingerprint in the Bitcoin Timechain – the world’s most secure and decentralized digital ledger.

Jeff Booth, general partner at ego death capital, shared his enthusiasm about the investment: “We are incredibly excited to be investors in Simple Proof. For the first time in history, we have a chance to break Orwell’s dictum of ‘Who controls the present, controls the past; and who controls the past, controls the future.’ Their technology ensures historical records remain intact and verifiable, preventing selective deletions. All history will be saved so we can all learn from our mistakes and correct them.”

Simple Proof’s solution addresses critical needs across the public sector, where government institutions face mounting challenges in maintaining trust in their digital records amid sophisticated disinformation campaigns. The platform is particularly valuable for protecting voting records, public documents, and digital evidence – providing indisputable proof of document integrity from the moment records are created.

“Our mission is to restore trust in digital information,” said Rafael Cordon, CEO of Simple Proof. “By anchoring critical records to the Bitcoin Timechain, we’re building the foundation for a future where digital authenticity is independently verifiable, not assumed.”

For more information about how Simple Proof is setting new standards for digital integrity, visit www.simpleproof.com

About Simple Proof
Simple Proof is a US-based technology company building Bitcoin-powered solutions for data integrity and verification. By combining enterprise-grade infrastructure with Bitcoin Timechain technology, Simple Proof enables organizations to create permanent, tamper-proof records of their digital files in a fast and easy way.

Contact
Rafa Cordon: media@simpleproof.com
https://x.com/realsimpleproof
NOSTR: npub145lf2q6sgqtkhjzzeza29ss6gz7qq4j6vslaa0dwanvgf58ey3us069hce

View original content to download multimedia:https://www.prnewswire.com/news-releases/simple-proof-raises-pre-seed-round-to-protect-digital-truth-using-bitcoin-technology-302358897.html

SOURCE Simple Proof

Continue Reading

Trending